|
Volumn 14, Issue 5, 2005, Pages 1209-1214
|
18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAGNOSTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
HODGKIN DISEASE;
HUMAN;
MALE;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION AND FORECASTING;
PROGNOSIS;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
ADOLESCENT;
ADULT;
AGED;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HODGKIN DISEASE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM, RESIDUAL;
POSITRON-EMISSION TOMOGRAPHY;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, X-RAY COMPUTED;
MLCS;
MLOWN;
|
EID: 27744560443
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.14.5.1209 Document Type: Article |
Times cited : (37)
|
References (0)
|